Home LiteratureArticle Details
PMID: 17981502 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Ubiquitin-proteasome system as a modulator of cell fate.

Current opinion in pharmacology ·Vol. 8 ·No. 1 ·2008-02-00 ·Pages 90-5

Thompson SJ, Loftus LT, Ashley MD, Meller R

Abstract

The ubiquitin-proteasome system is the major non-lysosymal system for degrading proteins in the cell; the work leading to its discovery was awarded the Nobel Prize in Chemistry in 2004. In addition to small ubiquitin-like modifiers (e.g. Sumo and Nedd8), ubiquitin is involved in the complex regulation of the levels and function of many proteins and signaling pathways involved in determining cell fate. The cell death regulatory proteins, such as Bcl-2 family proteins and caspases are targeted for degradation by the ubiquitin proteasome system (UPS). In addition to mediating the degradation of proteins, the UPS regulates function and translocation of proteins, many of which play a role in the determination of cell fate. For example the UPS can regulate the activity of transcription factors, such as P53, NF-kappaB and HIF-1 alpha, which control the expression of protein mediators of cell death. Aberrant UPS function has been reported in multiple neuropathologies including Parkinson's diseases and ischemia. With the number of ubiquitin conjugating and de-conjugating enzymes reaching close to the levels of protein kinases and phosphatases, it is clear that ubiquitination is an important biological regulatory step for proteins.

MeSH Terms
Animals Apoptosis Brain Ischemia/metabolism CASP8 and FADD-Like Apoptosis Regulating Protein/physiology Extracellular Signal-Regulated MAP Kinases/physiology Humans Hypoxia, Brain/metabolism Hypoxia-Inducible Factor 1, alpha Subunit/physiology Parkinson Disease/metabolism Proteasome Endopeptidase Complex/physiology Proto-Oncogene Proteins c-bcl-2/analysis Tumor Suppressor Protein p53/metabolism Ubiquitin/metabolism
Chemicals
CASP8 and FADD-Like Apoptosis Regulating Protein HIF1A protein, human Hypoxia-Inducible Factor 1, alpha Subunit Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 Ubiquitin Extracellular Signal-Regulated MAP Kinases Proteasome Endopeptidase Complex
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Thompson Simon J
RS Dow Neurobiology Laboratories, Legacy Clinical Research and Technology Center, 1225 Ne 2nd Avenue, Portland, OR 97232, USA.
Loftus Liam T
Ashley Michelle D
Meller Robert
References (59)
59 references, click to expand
  1. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells.
    Cancer Res. 2006 Sep 1;66(17):8858-69 PMID: 16951203
  2. Mutant genes responsible for Parkinson's disease.
    Curr Opin Pharmacol. 2004 Feb;4(1):79-84 PMID: 15018843
  3. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation.
    J Biol Chem. 2001 Nov 16;276(46):42938-44 PMID: 11557750
  4. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Science. 2003 Dec 12;302(5652):1972-5 PMID: 14671306
  5. Mechanisms underlying ubiquitination.
    Annu Rev Biochem. 2001;70:503-33 PMID: 11395416
  6. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.
    Semin Cell Dev Biol. 2000 Jun;11(3):141-8 PMID: 10906270
  7. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.
    Mol Cell. 2002 Jul;10(1):55-67 PMID: 12150907
  8. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation.
    Nat Cell Biol. 2003 May;5(5):461-6 PMID: 12717448
  9. Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival.
    EMBO J. 1991 Mar;10(3):555-62 PMID: 2001673
  10. Regulation of apoptosis proteins in cancer cells by ubiquitin.
    Oncogene. 2004 Mar 15;23(11):2009-15 PMID: 15021888
  11. Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1alpha in adult mouse brain and heart in vivo.
    FEBS Lett. 2004 Jul 2;569(1-3):293-300 PMID: 15225651
  12. Small-molecule-mediated rescue of protein function by an inducible proteolytic shunt.
    Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11209-14 PMID: 17563385
  13. Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm.
    J Biol Chem. 1994 Mar 11;269(10):7709-18 PMID: 8125997
  14. Impairment of the ubiquitin-proteasome system by cellular FLIP.
    Genes Cells. 2007 Jun;12(6):735-44 PMID: 17573774
  15. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis.
    Neuron. 2003 Jun 19;38(6):899-914 PMID: 12818176
  16. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim.
    J Biol Chem. 2003 May 23;278(21):18811-6 PMID: 12646560
  17. Transient global cerebral ischemia induces a massive increase in protein sumoylation.
    J Cereb Blood Flow Metab. 2008 Feb;28(2):269-79 PMID: 17565359
  18. Sumoylation increases HIF-1alpha stability and its transcriptional activity.
    Biochem Biophys Res Commun. 2004 Nov 5;324(1):394-400 PMID: 15465032
  19. Regulation of apoptosis signal-regulating kinase 1 degradation by G alpha13.
    FASEB J. 2007 Nov;21(13):3727-36 PMID: 17595347
  20. Signalling hypoxia by HIF hydroxylases.
    Biochem Biophys Res Commun. 2005 Dec 9;338(1):617-26 PMID: 16139242
  21. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain.
    J Biol Chem. 2002 Jan 4;277(1):486-91 PMID: 11679592
  22. BH3-ligand regulates access of MCL-1 to its E3 ligase.
    FEBS Lett. 2005 Oct 24;579(25):5603-8 PMID: 16213503
  23. Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia.
    Neuroscience. 2005;134(1):69-80 PMID: 15939539
  24. Chaperone functions of the E3 ubiquitin ligase CHIP.
    J Biol Chem. 2007 Aug 3;282(31):22267-77 PMID: 17545168
  25. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination.
    Cancer Res. 2006 Jun 15;66(12):6353-60 PMID: 16778213
  26. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling.
    J Neurosci. 2007 Feb 21;27(8):1868-78 PMID: 17314283
  27. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis.
    J Biol Chem. 2006 Nov 10;281(45):34124-34 PMID: 16980304
  28. Cell type-specific upregulation of Parkin in response to ER stress.
    Antioxid Redox Signal. 2007 May;9(5):533-42 PMID: 17465879
  29. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.
    Mol Biol Cell. 2007 Aug;18(8):3105-18 PMID: 17553932
  30. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
    Exp Cell Res. 2007 Aug 1;313(13):2858-74 PMID: 17512523
  31. Proteasome inhibitors: from research tools to drug candidates.
    Chem Biol. 2001 Aug;8(8):739-58 PMID: 11514224
  32. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.
    Cell. 2004 Sep 17;118(6):687-98 PMID: 15369669
  33. The role of the ubiquitin-proteasome pathway in apoptosis.
    Cell Death Differ. 1999 Apr;6(4):303-13 PMID: 10381632
  34. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
    Stroke. 2004 Jun;35(6):1506-18 PMID: 15118168
  35. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.
    Mol Cell Biol. 2000 Mar;20(5):1886-96 PMID: 10669763
  36. Monoubiquitylation promotes mitochondrial p53 translocation.
    EMBO J. 2007 Feb 21;26(4):923-34 PMID: 17268548
  37. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function.
    J Biol Chem. 2006 Jan 13;281(2):813-23 PMID: 16282323
  38. Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons.
    J Biol Chem. 2006 Mar 17;281(11):7429-36 PMID: 16431916
  39. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.
    Curr Biol. 2007 Mar 6;17(5):418-24 PMID: 17306544
  40. p53 ubiquitination: Mdm2 and beyond.
    Mol Cell. 2006 Feb 3;21(3):307-15 PMID: 16455486
  41. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.
    Neuron. 2003 Oct 30;40(3):595-607 PMID: 14642282
  42. The complexity of p53 stabilization and activation.
    Cell Death Differ. 2006 Jun;13(6):941-50 PMID: 16601750
  43. Inhibition of death receptor signals by cellular FLIP.
    Nature. 1997 Jul 10;388(6638):190-5 PMID: 9217161
  44. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway.
    J Exp Med. 1999 Jun 7;189(11):1815-22 PMID: 10359585
  45. Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimEL.
    J Biol Chem. 2005 May 6;280(18):17657-63 PMID: 15728578
  46. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
    Biochem Biophys Res Commun. 2007 Aug 31;360(3):646-52 PMID: 17610843
  47. SUMO--nonclassical ubiquitin.
    Annu Rev Cell Dev Biol. 2000;16:591-626 PMID: 11031248
  48. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.
    Cell. 2006 Feb 10;124(3):601-13 PMID: 16469705
  49. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
    Cancer Cell. 2007 May;11(5):407-20 PMID: 17482131
  50. Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway.
    Int J Oncol. 2002 Sep;21(3):597-601 PMID: 12168105
  51. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.
    Cell. 1999 Mar 5;96(5):635-44 PMID: 10089879
  52. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells.
    J Cereb Blood Flow Metab. 2007 May;27(5):950-62 PMID: 16955077
  53. A proteasome howdunit: the case of the missing signal.
    Cell. 2000 May 12;101(4):341-4 PMID: 10830160
  54. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration.
    Neurochem Int. 2006 Jul;49(2):106-12 PMID: 16759750
  55. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Science. 2001 Nov 9;294(5545):1307-13 PMID: 11588219
  56. Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle.
    Mov Disord. 2007 Feb 15;22(3):403-7 PMID: 17230468
  57. Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover.
    J Biol Chem. 2004 Mar 5;279(10):8837-47 PMID: 14681225
  58. Ubiquitin and ubiquitin-like proteins in protein regulation.
    Circ Res. 2007 May 11;100(9):1276-91 PMID: 17495234
  59. p53 Activation by nitric oxide involves down-regulation of Mdm2.
    J Biol Chem. 2002 May 3;277(18):15697-702 PMID: 11867628
Article Info
Journal
Current opinion in pharmacology
Abbr.
Curr Opin Pharmacol
ISSN
1471-4892
Published
2008-02-00
Epub
2007-00-05
Pages
90-5
Language
English
Region
England
NLM ID
100966133
PMCID
PMC2265078
Subset
IM
Grants
NINDS NIH HHS · R21 NS054023-01A1 · United States
NINDS NIH HHS · R01 NS039016-06A2 · United States
NINDS NIH HHS · R21 NS050669 · United States
NINDS NIH HHS · NS05402 · United States
NINDS NIH HHS · R21 NS054023 · United States
NINDS NIH HHS · R01 NS039016 · United States
NINDS NIH HHS · NS024728 · United States
NINDS NIH HHS · R01 NS024728-19A1 · United States
NINDS NIH HHS · R21 NS050669-01 · United States
NINDS NIH HHS · NS050669 · United States
NINDS NIH HHS · NS039016 · United States
NINDS NIH HHS · R01 NS024728 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com